求助文献全文，谢谢！

1. Villanueva A. Hepatocellular carcinoma. NEW ENGL J MED (2019) 15:1450-1462. doi: 10.1056/ NEJMra1713263

28. Hu X-S, Pan H-T, Zhou S, Pang Q, Wang Y, Zhu C, et al. HS1BP3, transcriptionally regulated by ESR1, promotes hepatocellular carcinoma progression. Biochem Biophys Res Commun (2022) 62 3:111-119. doi: 10.1016/j.bbrc.2022.07.047

31. Xu Y, Zhang X-F, Zhang R-T, Sun Y-N, Liu J, Luo C-J, et al. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations. Cancer Lett (2023) 566:216240.  doi: 10.1016/j.canlet.2023.216240

44. Martinek J, Wu T-C, Cadena D, Banchereau J, Palucka K. Interplay Between Dendritic Cells and Cancer Cells. Int Rev Cell Mol Biol (2019) 348:179–215. doi: 10.1016/ bs.irc- mb.2019.07.008

47. Zhao P, Bu X-C, Wei X-F, Sun W-H, Xie X-H, Li C-Y, et al. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Promotes Skewing toward Th2 Cytokine Profile in Patients with Metastatic Non-small Cell Lung Cancer. Int. Immunopharmacol (2015) 25,450456. doi: 10.1016/ j.intimp.2015.02.010

51. Dong Q, Yang B, Han JG, Zhang MM, Liu W, Zhang X, et al. A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/ AKT/mTOR and Ras/Raf/MEK/ERK signaling pathways. Cancer Lett. (2019) 455:60-72. doi:10. 1016/j. canlet.2019.04.031

54. Hao X, Li J, Liu B, Jing W, Guo Y, Liu F, et al. Cavin1 activates the Wnt/β-catenin pathway to influence the proliferation and migration of hepatocellular carcinoma. ANN HEPATOL. (2023) 29(1): 101160. doi: 10.1016/j.aohep. 2023.101160

55. Hu QR, Huang QX, Hong H, Pan Y, Luo T, Li J, et al. Ginsenoside Rh2 and its octyl- ester derivative inhibited invasion and metastasis of hepatocellular carcinoma via the c-Jun/ COX2/PGE2 pathway. PHYTOMEDICINE. (2023) 121:155131. doi:10.1016/ j. phymed. 2023.155131

56. Lou YX, Gu J, Zhu L, Sun SQ, Hao XL, Chen JP, et al.TC2N promotes cell proliferation and metastasis in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. LAB INVEST. (2023) 100260. doi:10.1016/ j.labinv. 2023.100260